CEST imaging for suspicious prostate lesions before biopsy
This study tests a new MRI-based method (called CEST) to help doctors better understand suspicious prostate areas before a biopsy, potentially improving accuracy and reducing unnecessary procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a prostate MRI finding called PI-RADS category 3, which means an area that looks suspicious but not definite cancer.
- You are scheduled for a targeted biopsy (a procedure to take tissue samples from that area).
- You are able to have an MRI scan safely (no metal implants, pacemaker, or severe claustrophobia).
- You have not had radiation therapy or chemotherapy for prostate cancer before.
- You have not had a prostate biopsy before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new MRI platform to better identify prostate issues before a biopsy. It is for people with elevated PSA whose doctor is considering a biopsy.
This trial tests a new type of MRI called CEST-MRI to better see prostate lesions. It may help find cancer more accurately than standard scans.
This study uses advanced MRI scans to better identify prostate cancer lesions before biopsy or surgery. It may help men who already have suspicious MRI findings and are scheduled for a prostate biopsy or removal.
This study tests a new way to guide prostate biopsies using a special scan (PSMA PET/CT) that highlights suspicious areas. If you need a biopsy because of high PSA and abnormal MRI, this approach might help make the biopsy more accurate.
This study uses a special MRI-guided (MRI-fusion) needle biopsy to look for early prostate cancer. It may help find concerning areas more accurately before cancer spreads.
This study tests if a special MRI measurement (ADC) can improve how well a standard MRI finds prostate cancer. If you have a suspicious MRI and are scheduled for a biopsy, this might help better understand your results.
Hear when a new Prostate Cancer Detection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.